Skip to content

Treatment of Obsessive compulsive symptoms in Psychotic disorders: Cognitive Behavioural Therapy

Treatment of Obsessive compulsive symptoms in Psychotic disorders: Cognitive Behavioural Therapy - TOP_CBT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON42610
Enrollment
88
Registered
2015-10-19
Start date
2016-01-07
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obsessive-compulsive disorder OCD in psychosis

Interventions

Manualized CBT will be applied over a period of 12 weeks.

Sponsors

Psychiatrie
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Obsessive-compulsive symptoms (YBOCS * 12 for at least 2 months) 2) Age range of 18 to 50 years 3) Diagnosis of a schizophrenia spectrum disorder according to the Diagnostic and Statistical Manual of Mental Disorders 5 5) Good command of the Dutch language 6) Able and willing to give written informed consent

Exclusion criteria

Exclusion criteria: 1) Rumination or repetitive behaviour solely related to psychotic symptoms. Positive symptoms as such are not an exclusion criterion; only when they are considered to be the primary cause of OCS-like symptoms or when they are so severe that primary treatment focused on positive symptoms is called for (more than one PANSS item of the positive subscale has a score of 5 or when one PANSS item of the positive subscale has a score of 6 or more). 2) Sever intellectual impairment, defined as an estimated IQ

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the change in OCS severity as assessed by the Yale-Brown-Obsessive-Compulsive Scale (YBOCS) compared to the waiting list condition.

Secondary

MeasureTime frame
Secondary endpoints are changes in symptoms of psychosis and depression, social functioning, and quality of life.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)